Pharmaceutical Supply and Packaging

The contract requires the manufacture, packaging, labeling, and supply of Benzoicaine Oral Topical Gel, 20%, in 1 oz units, adhering strictly to FDA current Good Manufacturing Practices and military packaging standards including MIL-STD-2073-1E and MIL-STD-129. All processes must ensure full compliance with federal pharmaceutical regulations and defense logistics requirements, with specific attention to product integrity, labeling accuracy, and packaging durability suitable for military use. The production must support consistent quality and traceability to meet the stringent demands of the Department of Defense supply chain. This is a subcontract opportunity under the NAICS code 325412, issued by the Medical Supply Chain Pharm FSA within the Department of Defense, with a response deadline of August 11, 2026. The solicitation was posted on August 5, 2026, and all work must be performed in accordance with the specified technical and logistical standards. While no set-aside provisions or point of contact details are provided, the place of performance and other administrative details are listed as unspecified, indicating flexibility in manufacturing location as long as all regulatory and military compliance criteria are met. Interested parties must submit proposals through the designated DLA Dibbs portal prior to the deadline.